Michael R. Liebowitz, MD

Article

A 12-Week Double-Blind, Placebo-Controlled, Flexible-Dose Trial of Vilazodone in Generalized Social Anxiety Disorder

November 26, 2015

Vilazodone shows many differences from the 4 already-approved medications for generalized social anxiety, but how safe is it? This trial tests the safety, efficacy and tolerability of the drug...

Jason M. Careri, Ann E. Draine, Rita Hanover, et al

Original Research

Six-Month Outcomes From a Randomized Trial Augmenting Serotonin Reuptake Inhibitors With Exposure and Response Prevention or Risperidone in Adults With Obsessive-Compulsive Disorder

April 22, 2015

Edna B. Foa, Helen Blair Simpson, David Rosenfield, et al

Original Research

Six-Month Follow-Up of a Randomized Controlled Trial Augmenting Serotonin Reuptake Inhibitor Treatment With Exposure and Ritual Prevention for Obsessive-Compulsive Disorder

May 15, 2013

Edna B. Foa, Helen Blair Simpson, Michael R. Liebowitz, et al

Article

Efficacy, Safety, and Tolerability of Desvenlafaxine 50 mg/d for the Treatment of Major Depressive Disorder: A Systematic Review of Clinical Trials

June 24, 2010

Read this article to review data on the clinical pharmacology, efficacy, safety, and tolerability of desvenlafaxine and to discover clinical practice considerations and future directions in desvenlafaxine research.

Michael R. Liebowitz, Karen A. Tourian

Original Research

Levetiracetam in Generalized Social Anxiety Disorder: A Double-Blind, Randomized Controlled Trial

December 15, 2009

Murray B. Stein, Lakshmi N. Ravindran, Naomi M. Simon, et al

Original Research

A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine Extended Release Capsules in Adult Outpatients With Panic Disorder

April 7, 2009

Michael R. Liebowitz, Gregory Asnis, Richard Mangano, et al

Academic Highlights

Easing the Burden of Social Anxiety Disorder

September 30, 2008

Michael R. Liebowitz, Franklin Schneier, Dan J. Stein, et al

Original Research

Generalizability of Clinical Trial Results for Major Depression to Community Samples: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

August 31, 2008

Carlos Blanco, Mark Olfson, Renee D. Goodwin, et al

Original Research

A Randomized, Double-Blind, Placebo-Controlled Trial of Desvenlafaxine Succinate in Adult Outpatients With Major Depressive Disorder

November 15, 2007

Michael R. Liebowitz, Paul P. Yeung, Richard Entsuah

Original Research

Response Versus Remission in Obsessive-Compulsive Disorder

February 15, 2006

Helen Blair Simpson, Jonathan D. Huppert, Eva Petkova, et al

Original Research

A Randomized Controlled Trial of Venlafaxine Extended Release in Generalized Social Anxiety Disorder

February 15, 2005

Michael R. Liebowitz, Richard M. Mangano, Jacques Bradwejn, et al

Article

Overview of Panic and Social Anxiety Disorders

December 15, 2004

Herman G. M. Westenberg, Michael R. Liebowitz

A 12-Week Double-Blind, Placebo-Controlled, Flexible-Dose Trial of Vilazodone in Generalized Social Anxiety Disorder

Six-Month Outcomes From a Randomized Trial Augmenting Serotonin Reuptake Inhibitors With Exposure and Response Prevention or Risperidone in Adults With Obsessive-Compulsive Disorder

Six-Month Follow-Up of a Randomized Controlled Trial Augmenting Serotonin Reuptake Inhibitor Treatment With Exposure and Ritual Prevention for Obsessive-Compulsive Disorder

Efficacy, Safety, and Tolerability of Desvenlafaxine 50 mg/d for the Treatment of Major Depressive Disorder: A Systematic Review of Clinical Trials

Levetiracetam in Generalized Social Anxiety Disorder: A Double-Blind, Randomized Controlled Trial

A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine Extended Release Capsules in Adult Outpatients With Panic Disorder

Easing the Burden of Social Anxiety Disorder

Generalizability of Clinical Trial Results for Major Depression to Community Samples: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

A Randomized, Double-Blind, Placebo-Controlled Trial of Desvenlafaxine Succinate in Adult Outpatients With Major Depressive Disorder

Response Versus Remission in Obsessive-Compulsive Disorder

A Randomized Controlled Trial of Venlafaxine Extended Release in Generalized Social Anxiety Disorder

Overview of Panic and Social Anxiety Disorders

ELSEWHERE:

FOLLOW US:

Michael R. Liebowitz, MD

A 12-Week Double-Blind, Placebo-Controlled, Flexible-Dose Trial of Vilazodone in Generalized Social Anxiety Disorder

Six-Month Outcomes From a Randomized Trial Augmenting Serotonin Reuptake Inhibitors With Exposure and Response Prevention or Risperidone in Adults With Obsessive-Compulsive Disorder

Six-Month Follow-Up of a Randomized Controlled Trial Augmenting Serotonin Reuptake Inhibitor Treatment With Exposure and Ritual Prevention for Obsessive-Compulsive Disorder

Efficacy, Safety, and Tolerability of Desvenlafaxine 50 mg/d for the Treatment of Major Depressive Disorder: A Systematic Review of Clinical Trials

Levetiracetam in Generalized Social Anxiety Disorder: A Double-Blind, Randomized Controlled Trial

A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine Extended Release Capsules in Adult Outpatients With Panic Disorder

Easing the Burden of Social Anxiety Disorder

Generalizability of Clinical Trial Results for Major Depression to Community Samples: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

A Randomized, Double-Blind, Placebo-Controlled Trial of Desvenlafaxine Succinate in Adult Outpatients With Major Depressive Disorder

Response Versus Remission in Obsessive-Compulsive Disorder

A Randomized Controlled Trial of Venlafaxine Extended Release in Generalized Social Anxiety Disorder

Overview of Panic and Social Anxiety Disorders

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles